MENU
+Compare
OMER
Stock ticker: NASDAQ
AS OF
Dec 23, 10:48 AM (EDT)
Price
$10.33
Change
+$0.02 (+0.19%)
Capitalization
596.88M

OMER Omeros Corp Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products

Industry Biotechnology
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for OMER with price predictions
Dec 20, 2024

OMER sees MACD Histogram just turned negative

OMER saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 10, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 47 instances where the indicator turned negative. In of the 47 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for OMER moved out of overbought territory on December 05, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 10, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on OMER as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OMER declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where OMER's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where OMER advanced for three days, in of 254 cases, the price rose further within the following month. The odds of a continued upward trend are .

OMER may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 202 cases where OMER Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OMER’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). OMER has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (256.215).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OMER’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OMER is expected to report earnings to rise 19.27% to -76 cents per share on February 26

Omeros Corp OMER Stock Earnings Reports
Q4'24
Est.
$-0.76
Q3'24
Beat
by $0.13
Q2'24
Missed
by $0.27
Q1'24
Missed
by $0.07
Q4'23
Beat
by $0.41
The last earnings report on November 13 showed earnings per share of -63 cents, beating the estimate of -76 cents. With 58.02K shares outstanding, the current market capitalization sits at 596.88M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
201 Elliott Avenue West
Phone
+1 206 676-5000
Employees
198
Web
https://www.omeros.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KTCIX47.510.53
+1.13%
DWS Science and Technology Inst
FCAGX31.340.30
+0.97%
Fidelity Advisor Small Cap Growth A
RWGFX4.650.04
+0.87%
Wedgewood Retail
TVOIX38.570.26
+0.68%
Touchstone Small Cap Value Institutional
SCVFX30.560.18
+0.59%
Allspring Small Company Value C

OMER and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OMER has been loosely correlated with VCYT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OMER jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMER
1D Price
Change %
OMER100%
+0.68%
VCYT - OMER
40%
Loosely correlated
+4.66%
FATE - OMER
38%
Loosely correlated
+1.20%
INM - OMER
36%
Loosely correlated
+6.25%
MRSN - OMER
31%
Poorly correlated
-8.05%
FULC - OMER
31%
Poorly correlated
+7.94%
More